STOCK TITAN

Clovis Oncology to Announce First Quarter 2021 Financial Results and Host Webcast Conference Call on May 5

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Clovis Oncology, Inc. (NASDAQ: CLVS) is set to release its first quarter 2021 financial results on May 5, 2021, prior to the US market opening. A conference call with senior management will be held at 8:30 a.m. ET to discuss the results in detail. Participants can join the call via dial-in numbers provided, with a dedicated international line available. The live event will also be streamed on Clovis' website, and a replay will be accessible for 30 days. The company focuses on innovative anti-cancer treatments in various global markets.

Positive
  • Scheduled release of first quarter 2021 financial results indicates transparency.
  • Conference call allows investors to engage with management for insights.
Negative
  • None.

Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its first quarter 2021 financial results on Wednesday, May 5, 2021, before the open of the US financial markets. Clovis’ senior management will host a conference call and live audio webcast at 8:30 a.m. ET to discuss the Company’s results in greater detail.

The conference call will be simultaneously webcast on the Clovis Oncology website www.clovisoncology.com, and a replay of the webcast will be available for 30 days.

Dial-in numbers for the conference call are as follows: US participants 877.698.7048 International participants 647.689.5448, conference ID: 3219208.

About Clovis Oncology

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing, and commercializing innovative anti-cancer agents in the US, Europe, and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops with partners diagnostic tools intended to direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado; please visit www.clovisoncology.com for more information, including additional office locations in the US and Europe.

FAQ

When will Clovis Oncology announce its first quarter 2021 financial results?

Clovis Oncology will announce its first quarter 2021 financial results on May 5, 2021.

What time is the conference call for Clovis Oncology's financial results?

The conference call will take place at 8:30 a.m. ET on May 5, 2021.

How can I participate in the Clovis Oncology conference call?

Participants can join the conference call by dialing 877.698.7048 for US callers or 647.689.5448 for international callers, using conference ID 3219208.

Will Clovis Oncology's conference call be available for replay?

Yes, a replay of the conference call will be available for 30 days after the event.

What is Clovis Oncology's focus as a biopharmaceutical company?

Clovis Oncology is focused on developing and commercializing innovative anti-cancer agents.

CLVS

NASDAQ:CLVS

CLVS Rankings

CLVS Latest News

CLVS Stock Data

11.77M
142.86M
1.44%
25.9%
19.65%
Biotechnology
Healthcare
Link
United States
Boulder